Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study …
MJ Davies, VR Aroda, BS Collins, RA Gabbay… - Diabetes …, 2022 - Am Diabetes Assoc
The American Diabetes Association and the European Association for the Study of Diabetes
convened a panel to update the previous consensus statements on the management of …
convened a panel to update the previous consensus statements on the management of …
Pathophysiological molecular mechanisms of obesity: a link between MAFLD and NASH with cardiovascular diseases
J Gutiérrez-Cuevas, A Santos… - International Journal of …, 2021 - mdpi.com
Obesity is now a worldwide epidemic ensuing an increase in comorbidities' prevalence,
such as insulin resistance, type 2 diabetes (T2D), metabolic dysfunction-associated fatty …
such as insulin resistance, type 2 diabetes (T2D), metabolic dysfunction-associated fatty …
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the …
Abstract The American Diabetes Association and the European Association for the Study of
Diabetes convened a panel to update the previous consensus statements on the …
Diabetes convened a panel to update the previous consensus statements on the …
[HTML][HTML] Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis
J Hwang, H Hwang, H Shin, BH Kim… - Clinical and …, 2024 - pmc.ncbi.nlm.nih.gov
Methods We searched various databases including PubMed, OVID Medline, EMBASE, and
Cochrane Library. Primary outcomes were the changes in intrahepatic fat on MRI-PDFF and …
Cochrane Library. Primary outcomes were the changes in intrahepatic fat on MRI-PDFF and …
Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes
E Lembo, MF Russo, O Verrastro, D Anello… - Diabetes & …, 2022 - Elsevier
Aim To investigate the prevalence of biopsy-proven non-alcoholic steatohepatitis (NASH) in
a cohort of patients with morbid obesity and with or without type 2 diabetes (T2D) and to find …
a cohort of patients with morbid obesity and with or without type 2 diabetes (T2D) and to find …
Impacts of bariatric surgery on adverse liver outcomes: a systematic review and meta-analysis
G Wang, Y Huang, H Yang, H Lin, S Zhou… - Surgery for Obesity and …, 2023 - Elsevier
Background Bariatric surgery has been reported to improve degeneration, inflammation, and
fibrosis in nonalcoholic fatty liver disease, but the effects of bariatric surgery on the …
fibrosis in nonalcoholic fatty liver disease, but the effects of bariatric surgery on the …
Regression of nonalcoholic fatty liver disease is associated with reduced risk of incident diabetes: A longitudinal cohort study
Objective Non-alcoholic fatty liver disease (NAFLD) is potentially reversible. However,
whether improvement of NAFLD leads to clinical benefits remains uncertain. We …
whether improvement of NAFLD leads to clinical benefits remains uncertain. We …
[HTML][HTML] Can liquid biopsies for MASH help increase the penetration of metabolic surgery? A narrative review
L Castagneto-Gissey, SR Bornstein, G Mingrone - Metabolism, 2024 - Elsevier
This narrative review highlights current evidence on non-invasive tests to predict the
presence or absence as well as the severity of metabolic dysfunction-associated …
presence or absence as well as the severity of metabolic dysfunction-associated …
The effects of laparoscopic Roux-en-Y gastric bypass and one-anastomosis gastric bypass on glycemic control and remission of type 2 diabetes mellitus: study …
A van Rijswijk, N van Olst, AS Meijnikman… - Trials, 2022 - Springer
Background Metabolic surgery induces rapid remission of type 2 diabetes mellitus (T2DM).
There is a paucity of high level evidence comparing the efficacy of the laparoscopic Roux-en …
There is a paucity of high level evidence comparing the efficacy of the laparoscopic Roux-en …
Preoperative circulating peroxiredoxin 1 levels as a predictor of non-alcoholic fatty liver disease remission after laparoscopic bariatric surgery
X Cheng, Z Fu, W Xie, L Zhu, J Meng - Frontiers in endocrinology, 2022 - frontiersin.org
Background Non-alcoholic fatty liver disease (NAFLD) is associated with obesity and insulin
resistance and can be improved after bariatric surgery. Circulating Peroxiredoxin 1 (Prdx1) …
resistance and can be improved after bariatric surgery. Circulating Peroxiredoxin 1 (Prdx1) …